ACADIA Pharmaceuticals Inc. news

   Watch this stock
Showing stories 1 - 10 of about 80   

Articles published

ACAD 28.05 +0.42 (1.52%)
price chart
This Is A Good Time To Buy Acadia Pharmaceuticals (ACAD)
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) is in the process of a filing a new drug application (NDA) for Nuplazid (pimavanserin), which is a first-in-class treatment for Parkinson's disease psychosis, or PDP.
Related articles »  
Trader's Watch List: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), SunEdison ...
ACADIA Pharmaceuticals (NASDAQ:ACAD) CEO Uli Hacksell sold 30,000 shares of ACADIA Pharmaceuticals stock in a transaction that occurred on Wednesday, October 8th.
First Week of June 2015 Options Trading For Acadia Pharmaceuticals (ACAD)
Investors in Acadia Pharmaceuticals Inc (Symbol: ACAD) saw new options become available this week, for the June 2015 expiration.
Stock Runners: CEMEX, S.A.B. de C.V. (NYSE:CX), ACADIA Pharmaceuticals ...
On 23 October CEMEX, S.A.B. de C.V (NYSE:CX) posted its quarterly earnings results on Thursday. The company reported ($0.08) earnings per share for the quarter, missing the analysts' consensus estimate of $0.01 by $0.09.
Active Movers -Life Time Fitness, Inc. (NYSE:LTM),ACADIA Pharmaceuticals Inc ...
Las Vegas, NV - OCT 27, 2014 - (Tech Sonian) - Life Time Fitness, Inc. (NYSE:LTM) recently reported that its financial results for the third quarter ended September 30, 2014.
Related articles »  
Biotech Stocks Technical Insight - Incyte, Regado Biosciences, ACADIA Pharma ...
ACADIA Pharmaceuticals Inc.'s stock declined 4.17% to end Thursday's session at $25.71. The stock recorded a trading volume of 1.29 million shares, above its three months average volume of 1.18 million shares.
Related articles »  
Today's Stocks: NVIDIA Corporation (NASDAQ:NVDA), ACADIA ...
On last trading day company shares ended up $18.55. NVIDIA Corporation (NASDAQ:NVDA) distance from 50-day simple moving average (SMA50) is -1.54%.
Related articles »  
What is meant by High Beta Stock? Intersil Corp (ISIL), ACADIA Pharmaceuticals ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is currently valued at $2.57 billion. The company has 99.44 million shares outstanding and 95.60% shares of the company were owned by institutional investors.
Insider Selling: Uli Hacksell Unloads 30000 Shares of ACADIA Pharmaceuticals ...
Analysts expect that ACADIA Pharmaceuticals will post $-0.86 EPS for the current fiscal year. ACADIA Pharmaceuticals Inc is a biopharmaceutical company focused on small molecule drugs that address unmet medical needs in neurological and related ...
Related articles »  
ACADIA Pharmaceuticals CEO Sells $724500 in Stock (ACAD)
Shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) traded down 3.15% on Friday, hitting $23.40. 951,429 shares of the company's stock traded hands. ACADIA Pharmaceuticals has a one year low of $15.64 and a one year high of $32.00. The stock's ...
Related articles »